These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10970828)

  • 1. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.
    Kikuchi T; Abe T; Yaekashiwa M; Tominaga Y; Mitsuhashi H; Satoh K; Nakamura T; Nukiwa T
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):364-70. PubMed ID: 10970828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
    Abe T; Kobayashi N; Yoshimura K; Trapnell BC; Kim H; Hubbard RC; Brewer MT; Thompson RC; Crystal RG
    J Clin Invest; 1991 Jun; 87(6):2207-15. PubMed ID: 1674946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma.
    Takami Y; Motoki T; Yamamoto I; Gohda E
    Biochem Biophys Res Commun; 2005 Feb; 327(1):212-7. PubMed ID: 15629451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial pneumonia causes augmented expression of the secretory leukoprotease inhibitor gene in the murine lung.
    Abe T; Tominaga Y; Kikuchi T; Watanabe A; Satoh K; Watanabe Y; Nukiwa T
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1235-40. PubMed ID: 9351627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
    Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
    J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of secretory leukoprotease inhibitor gene expression].
    Kikuchi T; Abe T
    Nihon Rinsho; 1996 Feb; 54(2):405-10. PubMed ID: 8838088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
    Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
    J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
    Rao NV; Marshall BC; Gray BH; Hoidal JR
    Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cis-acting region associated with lung cell-specific expression of the secretory leukoprotease inhibitor gene.
    Kikuchi T; Abe T; Satoh K; Narumi K; Sakai T; Abe S; Shindoh S; Matsushima K; Nukiwa T
    Am J Respir Cell Mol Biol; 1997 Sep; 17(3):361-7. PubMed ID: 9308923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
    Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
    Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatocyte growth factor induction in human dermal fibroblasts by interleukin-1 and its prevention by interferon-gamma.
    Takami Y; Kanasaki K; Tsubouchi H; Ishii T; Yamamoto I; Gohda E
    Biochem Biophys Res Commun; 2004 Dec; 325(3):676-82. PubMed ID: 15541342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate, the slime exopolysaccharide of Pseudomonas aeruginosa, binds human leukocyte elastase, retards inhibition by alpha 1-proteinase inhibitor, and accelerates inhibition by secretory leukoprotease inhibitor.
    Ying QL; Kemme M; Simon SR
    Am J Respir Cell Mol Biol; 1996 Aug; 15(2):283-91. PubMed ID: 8703486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis.
    Marchand-Adam S; Fabre A; Mailleux AA; Marchal J; Quesnel C; Kataoka H; Aubier M; Dehoux M; Soler P; Crestani B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):58-66. PubMed ID: 16574935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hepatocyte growth factor production by aging human fibroblasts mainly due to autocrine stimulation by interleukin-1.
    Miyazaki M; Gohda E; Kaji K; Namba M
    Biochem Biophys Res Commun; 1998 May; 246(1):255-60. PubMed ID: 9600102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.